
James M. Cleary, MD, PhD, is a medical oncologist specializing in gastrointestinal oncology and an Associate Professor of Medicine at Harvard Medical School. He cares for patients at Dana-Farber Cancer Institute where he serves as Co-Director of Clinical Trials in the Center for Gastrointestinal Oncology. His clinical focus includes gastrointestinal oncology and translational research. His research centers on developing targeted and immune-based therapies for gastrointestinal malignancies, leveraging DNA damage repair biology, and advancing biomarker-driven drug development. Dr. Cleary has been recognized at Dana-Farber for exceptional patient care and at Harvard Medical School for excellence in teaching, and he co-leads a Stand Up To Cancer/Lustgarten Foundation initiative in DNA repair therapeutics. He attended Rutgers College and earned his MD and PhD from the Albert Einstein College of Medicine. He completed internal medicine residency at Massachusetts General Hospital, and pursued fellowship training in medical oncology at Dana-Farber Cancer Institute.
Associate Professor
Medical School
2003
Residency
Fellowship